Skip to main content
Subscribe
Register
Sign in
Membership
Events
Knowledge Center
About
Subscribe
Register
Sign in
Allergan
Latest Articles
U.S. M&A Could Rebound as Companies See Few Other Growth Options
Dan Weil
July 6, 2016
The Morning Brief: Icahn Joins Hedgies in Allergan Trade
Stephen Taub
June 1, 2016
Golden Parachutes Leave Investors Fearing Conflict of Interest
Jeff Ostrowski
May 17, 2016
Perella Weinberg’s Andrew Bednar Drives Stock Exchange Megadeals
David Rothnie
April 19, 2016
The Morning Brief: March Gains Trim Hefty Losses at Omega, Glenview
Stephen Taub
April 11, 2016
The Morning Brief: Emerging Markets Funds Got a Boost in March
Stephen Taub
April 8, 2016
Minding the Gap Between GAAP, Pro Forma Earnings
Dan Weil
March 17, 2016
Premium
Jana Partners Continues As It Finished the Year: Down
Stephen Taub
February 2, 2016
The Morning Brief: Alcoa Trades Expanded Board for Elliott’s Support
Stephen Taub
February 2, 2016
Inbound M&A Adds Fuel to a Hot Deal Market
Dan Weil
December 23, 2015
Allergan-Pfizer Merger Gives Pharma a Growth Injection
Anne Szustek
December 16, 2015
Daily Agenda: Commodity Rout Continues
Andrew Barber
November 23, 2015
Daily Agenda: Liquidity Fuels Continuing M&A Boom
Andrew Barber
October 30, 2015
Daily Agenda: Gravity Returns to Chinese Stock Market
Andrew Barber
July 27, 2015
The Morning Brief: Elliott Discloses CDK Global Stake
Stephen Taub
May 13, 2015
Premium
The 2015 Rich List: The Highest Earning Hedge Fund Managers of the Past Year
Stephen Taub
May 5, 2015
Premium
Jana Records a Slightly Down March as Volatilty Hits
Stephen Taub
April 1, 2015
Actavis CEO Brent Saunders Has a Vision for Growth
Anne Szustek
March 12, 2015
More Articles